Correction to: Cost Effectiveness of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors, Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists, and Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: A Systematic Review (PharmacoEconomics, (2019), 37, 6, (777-818), 10.1007/s40273-019-00774-9)

Dongzhe Hong, Lei Si, Minghuan Jiang, Hui Shao, Wai kit Ming, Yingnan Zhao, Yan Li, Lizheng Shi

Research output: Contribution to journal › Comment/debate

5 Scopus citations

Fingerprint

Dive into the research topics of 'Correction to: Cost Effectiveness of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors, Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists, and Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: A Systematic Review (PharmacoEconomics, (2019), 37, 6, (777-818), 10.1007/s40273-019-00774-9)'. Together they form a unique fingerprint.

Medicine & Life Sciences

Social Sciences